Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

CareDx to Participate in Upcoming Investor Conferences


Posted on: 02 Nov 17

BRISBANE, Calif, Feb. 07, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that Peter Maag, Chief Executive Officer, and Michael Bell, Chief Financial Officer, will be participating in four upcoming investor conferences.

Leerink Partners 7th Annual Global Healthcare Conference in New York City

  • Peter Maag will host investor meetings on Thursday, February 15th

BTIG Healthcare Conference in Snowbird, Utah

  • Peter Maag will host investor meetings on Wednesday and Thursday, February 28th and March 1st

30th Annual Roth Conference in Laguna Niguel, California

  • Peter Maag and Michael Bell will host investor meetings on Monday and Tuesday, March 12th and 13th

H. C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco

  • Peter Maag will present on Monday, April 9th, and host investor meetings on Monday and Tuesday, April 9th and 10th

A live audio webcast of the H. C. Wainwright Global Life Sciences Conference will be available online from the investor relations section of the CareDx website at http://investors.caredx.com. The webcast replay of the presentation will be available approximately one hour following the conclusion of the live presentation and will be available on the Company’s website for 90 days. Management will be hosting one-on-one meetings for the Leerink Partners 7th Annual Global Healthcare Conference, the BTIG Healthcare Conference and the 30th Annual Roth Conference and no webcasts will be available for these events.

About CareDx
CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products across the transplant testing continuum, including AlloMap® and AlloSure™ for post-transplant surveillance and Olerup SSP®, Olerup QTYPE®, and Olerup SBT™ for pre-transplant HLA testing.

For more information, please visit: www.CareDx.com.

CONTACTS:

CareDx, Inc.
Sasha King
Chief Commercial Officer
415-287-2393
sking@caredx.com

Investor Relations
David Clair
Integrated Corporate Relations, Inc.
646-277-1266
david.clair@icrinc.com

GlobeNewswire
globenewswire.com

Last updated on: 07/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.